The Dopamine Hypothesis of Schizophrenia: An Historical and ...
The Dopamine Hypothesis of Schizophrenia: An Historical and ...
The Dopamine Hypothesis of Schizophrenia: An Historical and ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
60 ■ PPP / Vol. 18, No. 1 / March 2011<br />
References<br />
Abi-Dargham, A. 2004. Do we still believe in the dopamine<br />
hypothesis? New data bring new evidence.<br />
International Journal <strong>of</strong> Neuropsychopharmacology<br />
7, Suppl 1:S1–S5.<br />
Abi-Dargham, A., J. Rodenhiser, D. Printz, Y. Zea-<br />
Ponce, R. et al. 2000. Increased baseline occupancy<br />
<strong>of</strong> D2 receptors by dopamine in schizophrenia.<br />
Proceedings <strong>of</strong> the National Academy <strong>of</strong> Science U<br />
S A 97:8104–9.<br />
Aghajanian, G. K., <strong>and</strong> B. S. Bunney. 1977.<br />
<strong>Dopamine</strong>”autoreceptors”: Pharmacological<br />
characterization by microiontophoretic single cell<br />
recording studies. Naunyn Schmiedebergs Archives<br />
<strong>of</strong> Pharmacology 297, no. 1:1–7.<br />
Amin, F., M. Davidson, R. S. Kahn, J. Schmeidler, et al.<br />
1995. Assessment <strong>of</strong> the central dopaminergic index<br />
<strong>of</strong> plasma HVA in schizophrenia. <strong>Schizophrenia</strong> Bulletin<br />
21, no. 1:53–66.<br />
<strong>An</strong>dreasen, N. C. 1981. Scale for the assessment <strong>of</strong><br />
negative symptoms (SANS). Iowa City: <strong>The</strong> University<br />
<strong>of</strong> Iowa.<br />
<strong>An</strong>grist, B., H. K. Lee, <strong>and</strong> S. Gershon. 1974. <strong>The</strong> antagonism<br />
<strong>of</strong> amphetamine-induced symptomatology<br />
by a neuroleptic. American Journal <strong>of</strong> Psychiatry<br />
131, no. 7:817–9.<br />
Baumeister, A. A., <strong>and</strong> J. L. Francis. 2002. <strong>Historical</strong><br />
development <strong>of</strong> the dopamine hypothesis <strong>of</strong> schizophrenia.<br />
Journal <strong>of</strong> History Neuroscience 11, no.<br />
3:265–77.<br />
Bennett, C. L. 2005. Astrophysical observations: Lensing<br />
<strong>and</strong> eclipsing Einstein’s theories. Science 307,<br />
no. 5711:879–84.<br />
Borglum, A. D., M. Hampson, T. E. Kjeldsen, W. Muir,<br />
et al. 2001. Dopa decarboxylase genotypes may<br />
influence age at onset <strong>of</strong> schizophrenia. Molecular<br />
Psychiatry 6, no. 6:712–7.<br />
Brown, T. M. 1970. <strong>The</strong> College <strong>of</strong> Physicians <strong>and</strong> the<br />
acceptance <strong>of</strong> iatromechanism in Engl<strong>and</strong>, 1665–<br />
1695. Bulletin <strong>of</strong> the History <strong>of</strong> Medicine 44:12–30.<br />
Buchanan, R. W., <strong>and</strong> W. T. Carpenter Jr. 2005. <strong>Schizophrenia</strong><br />
<strong>and</strong> other psychotic disorders. In Kaplan &<br />
Sadock’s Comprehensive textbook <strong>of</strong> psychiatry, volume<br />
1, ed. B. J. Sadock, <strong>and</strong> V. A. Sadock, 1329–558.<br />
New York: Lippincott Williams & Wilkins.<br />
Bunzow, J. R., H. H. Van Tol, D. K. Gr<strong>and</strong>y, P. Albert,<br />
et al. 1988. Cloning <strong>and</strong> expression <strong>of</strong> a rat D2 dopamine<br />
receptor cDNA. Nature 336, no. 6201:783–7.<br />
Carlsson, A. 1978. Does dopamine have a role in<br />
schizophrenia? Biological Psychiatry 13, no. 1:3–21.<br />
——–. 2001. A half-century <strong>of</strong> neurotransmitter research:<br />
Impact on neurology <strong>and</strong> psychiatry (Nobel<br />
lecture). Chembiochem 2, no 7–8:484–93.<br />
Carlsson, A., <strong>and</strong> Y. Lecrubier. 2004. Progress in dopamine<br />
research in schizophrenia: A guide for physicians.<br />
London: Taylor & Francis Group.<br />
Carlsson, A., <strong>and</strong> M. Lindqvist. 1963. Effect <strong>of</strong> chlorpromazine<br />
or haloperidol on formation <strong>of</strong> 3-methoxytyramine<br />
<strong>and</strong> normetanephrine in mouse brain.<br />
Acta Pharmacologica et Toxicology 20:140–4.<br />
Chamberlin, T. C. 1897. <strong>The</strong> method <strong>of</strong> multiple working<br />
hypotheses. Journal <strong>of</strong> Geology 5:837–48.<br />
Cohen, B. J. 2003. <strong>The</strong>ory <strong>and</strong> practice <strong>of</strong> psychiatry.<br />
Oxford: Oxford University Press.<br />
Connell, P. H. 1958. Amphetamine psychosis. In Maudsley<br />
monographs, No. 5, Institute <strong>of</strong> Psychiatry.<br />
London: Chapman <strong>and</strong> Hall, Ltd.<br />
Creese, I., D. R. Burt, <strong>and</strong> S. H. Snyder. 1976. <strong>Dopamine</strong><br />
receptor binding predicts clinical <strong>and</strong> pharmacological<br />
potencies <strong>of</strong> antischizophrenic drugs. Science 192,<br />
no. 4238:481–3.<br />
Crow, T. J. 1980. Molecular pathology <strong>of</strong> schizophrenia:<br />
More than one disease process? British Medical<br />
Journal 280, no. 6207:66–8.<br />
Csernansky, J. G., <strong>and</strong> J. W. Newcomer. 1994. Are <strong>The</strong>re<br />
neurochemical indicators <strong>of</strong> risk for schizophrenia.<br />
<strong>Schizophrenia</strong> Bulletin 20, no. 1:75–88.<br />
Cutler, N. R., D. V. Jeste, C. A. Kaufmann, F. Karoum,<br />
et al. 1984. Low dose bromocriptine: A study <strong>of</strong><br />
acute effects in chronic mediated schizophrenics.<br />
Progress Neuro-Psychopharmacology & Biological<br />
Psychiatry 8, no. 2:277–83.<br />
Dahlstrom, A., <strong>and</strong> K. Fuxe. 1964. Evidence for the<br />
existence <strong>of</strong> monoamine-containing neurons in the<br />
central nervous system. I. Demonstration <strong>of</strong> monoamines<br />
in the cell bodies <strong>of</strong> brain stem neurons. Acta<br />
Physiologica Sc<strong>and</strong>inavica Suppl 232:1.<br />
Dahlstrom, A., K. Fuxe, L. Olson, <strong>and</strong> U. Ungerstedt.<br />
1962. Ascending systems <strong>of</strong> catecholamine neurons<br />
from the lower brainstem. Acta Physiologica Sc<strong>and</strong>inavica<br />
62:485–6.<br />
Davis, K. L., R. S. Kahn, G. Ko, <strong>and</strong> M. Davidson.<br />
1991. <strong>Dopamine</strong> in schizophrenia: A review <strong>and</strong><br />
reconceptualization. American Journal <strong>of</strong> Psychiatry<br />
148, no. 11:1474–86.<br />
Depatie, L., <strong>and</strong> S. Lal. 2001. Apomorphine <strong>and</strong> the<br />
dopamine hypothesis <strong>of</strong> schizophrenia: A dilemma?<br />
Journal <strong>of</strong> Psychiatry & Neuroscience 26, no.<br />
3:203–20.<br />
Donnelly, C. L., J. P. McElvoy, W. H. Wilson, <strong>and</strong> N.<br />
Narasimhachari. 1996. A study <strong>of</strong> the potential<br />
confounding effects <strong>of</strong> diet, caffeine, nicotine <strong>and</strong><br />
lorazepam on the stability <strong>of</strong> plasma <strong>and</strong> urinary homovanillic<br />
acid levels in patients with schizophrenia.<br />
Biological Psychiatry 40, no. 12:1218–21.